Zhijie Wang
Clinical trials sponsored by Zhijie Wang, explained in plain language.
-
Promising combo targets rare lung cancer in new trial
Disease control Not yet recruitingThis study tests a combination of anlotinib pills and standard chemotherapy for people with a rare, advanced lung cancer that lacks the SMARCA4 gene. The goal is to see if this combo can delay cancer growth and what side effects occur. About 28 adults with this specific tumor typ…
Phase: PHASE2 • Sponsor: Zhijie Wang • Aim: Disease control
Last updated May 26, 2026 11:23 UTC
-
New drug combo targets rare, aggressive lung cancer in early trial
Disease control Not yet recruitingThis study tests a new two-in-one immunotherapy drug (iparomlimab and tuvonralimab) plus chemotherapy as a first treatment for people with a rare, advanced lung cancer that lacks the SMARCA4 gene. The goal is to see if this combination can shrink tumors or slow the cancer's growt…
Phase: PHASE2 • Sponsor: Zhijie Wang • Aim: Disease control
Last updated May 22, 2026 14:01 UTC